Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

"We thank our stockholders for their support through our time as a public company and the duration of this process,” said Nick Green, president and CEO of Avid Bioservices. "We look forward to ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Fermentation's role in biotechnology spans millennia, impacting food production and paving the way for advancements in ...

Legend Biotech Corporation (NASDAQ:LEGN), with a market capitalization of $6.74 billion, has emerged as a prominent player in the biotechnology sector, primarily due to the success of its flagship ...

Macquarie University researchers have worked with an international team of scientists to achieve a major milestone in ...

Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...

A Winnipeg-based biotechnology company says it's open to any financial help it can get from Ottawa as the U.S. continues to ...

A study has introduced a novel bioprocess that transforms CO2 and electricity into single-cell protein (SCP), a sustainable ...

Researchers at Durham University have achieved a major advancement in understanding how proteins bind metals inside cells, a process ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...